New findings to be presented at the 2025 European Association for the Study of the Liver (EASL) Congress continue to ...

Tragically, it was not the cancer but the treatment he received at Llandough Hospital in Penarth that would ultimately, in ...

Gilead Sciences (NasdaqGS:GILD) recently announced a presentation at the EASL Congress focusing on liver disease, with ...

Patients who use opioids have better results but higher discontinuation rates with methadone than with safer opioid supply, ...

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

Liver transplantation is the sole curative option for HCC, but new therapies prompt reconsideration of transplant timing and ...

An NHS GP has highlighted the early signs of a killer disease - which has risen by a shocking amount in recent years. Dr Mark ...

As more inmates seek to transfer in from male facilities, “one community’s safety cannot come at the cost of another’s.” ...

The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.

Hispanic/Latinx and White children have more than twofold and threefold increased odds of linkage to care, respectively, than Black children.

A combination of pertuzimab and Enhertu can slow disease progression and improve survival in people with HER2-positive ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...